Cargando…

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer

The solute carrier (SLC) family is the largest group of membrane transporters, but their functions in ovarian cancer (OV) remain unclear. We analyzed SLC family members with amino acids-transporting functions in OV. The mRNA expression levels and prognostic values of SLCs in OV were analyzed in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Tianshui, Bi, Fangfang, Liu, Zhuonan, Yang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377849/ https://www.ncbi.nlm.nih.gov/pubmed/32647070 http://dx.doi.org/10.18632/aging.103433

Ejemplares similares

Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
por: Sun, Tianshui, et al.
Publicado: (2021)

TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway
por: Sun, Tianshui, et al.
Publicado: (2021)

PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2021)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

Corrigendum: PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2022)

SLC11A2: a promising biomarker and therapeutic target in ovarian cancer
por: Tian, Liming, et al.
Publicado: (2023)

The role of ubiquitination and deubiquitination in cancer metabolism
por: Sun, Tianshui, et al.
Publicado: (2020)

Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target
por: Zhu, Zheng, et al.
Publicado: (2021)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)

Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer
por: Xu, Fangfang, et al.
Publicado: (2021)

Hypoxia–Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma
por: Li, Wenjin, et al.
Publicado: (2022)

Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target
por: Gao, Qiang, et al.
Publicado: (2014)

SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
por: Cheng, Xin, et al.
Publicado: (2022)

PB1804: SLC7A11 IS A POTENTIAL THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
por: LI, Jiazheng, et al.
Publicado: (2023)

SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome
por: Ma, Yan, et al.
Publicado: (2015)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression
por: Liu, Zhuonan, et al.
Publicado: (2021)

METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
por: Liu, Zhuonan, et al.
Publicado: (2022)

Upregulation of ADAR Promotes Breast Cancer Progression and Serves as a Potential Therapeutic Target
por: Li, Xiao, et al.
Publicado: (2021)

IRF7 and CTSS are pivotal for cutaneous wound healing and may serve as therapeutic targets
por: Yin, Jiali, et al.
Publicado: (2023)

Long Noncoding RNAs Serve as Potential Diagnostic Biomarkers for Colorectal Cancer
por: Cai, Juan, et al.
Publicado: (2019)

SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
por: Shan, Qingqing, et al.
Publicado: (2023)

CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
por: Ying, Xue, et al.
Publicado: (2021)

The Role of SLC7A11 in Cancer: Friend or Foe?
por: Li, Sijia, et al.
Publicado: (2022)

TET-dependent GDF7 hypomethylation impairs aqueous humor outflow and serves as a potential therapeutic target in glaucoma
por: Wan, Peixing, et al.
Publicado: (2021)

UQCRFS1 serves as a prognostic biomarker and promotes the progression of ovarian cancer
por: Sun, Qiran, et al.
Publicado: (2023)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

The Identification of RNA Modification Gene PUS7 as a Potential Biomarker of Ovarian Cancer
por: Li, Huimin, et al.
Publicado: (2021)

A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer
por: Li, He, et al.
Publicado: (2022)

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
por: Kumar, Juhi, et al.
Publicado: (2019)

CEMIP as a potential biomarker and therapeutic target for breast cancer patients
por: Xue, Jinqi, et al.
Publicado: (2022)

M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection
por: Zhang, Hanwen, et al.
Publicado: (2021)

MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target
por: Wang, Yifei, et al.
Publicado: (2022)

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma
por: Ru, Guo-Qing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g6n55stprieeqaafb34rld5ntb